View Older Stories View More Recent Stories

Oct 6, 2026 06:54AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Oct 5, 2026 04:02PM BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
Oct 5, 2026 12:21PM Jefferies Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Oct 5, 2026 10:43AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Oct 5, 2026 07:44AM BridgeBio Pharma (BBIO) Reiterated at Overweight by Cantor Fitzgerald
Oct 5, 2026 07:31AM BridgeBio cardiac data shows BBP-418 benefit in muscle disease trial
Oct 1, 2026 03:00PM 3 high-conviction SMID-cap biotech stocks to buy: Jefferies
Sep 10, 2026 06:49AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 2, 2026 06:55AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Aug 31, 2026 03:16PM Trump announces nine more pharma firms in drug pricing deals
Aug 31, 2026 01:59PM BridgeBio Pharma (BBIO) PT Raised to $110 at Mizuho
Aug 31, 2026 06:04AM BridgeBio's acoramidis shows cardiac reversal data at ESC 2026
Aug 26, 2026 07:33AM BridgeBio doses first patient in Phase 3b/4 acoramidis heart study
Aug 12, 2026 06:54AM BridgeBio Pharma (BBIO) PT Raised to $106 at Canaccord
Aug 11, 2026 09:54AM BridgeBio Pharma (BBIO) PT Raised to $115 at Piper Sandler as 'Attruby Outperforms'
Aug 11, 2026 09:44AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO), Updates Estimates
Aug 11, 2026 06:57AM BridgeBio Pharma (BBIO) PT Raised to $102 at Wells Fargo
Aug 10, 2026 04:33PM BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 18c
Jul 24, 2026 07:26AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 22, 2026 07:31AM FDA accepts BridgeBio NDA for encaleret to treat ADH1
Jul 13, 2026 06:41AM BridgeBio Pharma (BBIO) PT Raised to $120 at H.C. Wainwright
Jul 2, 2026 07:31AM BridgeBio drug shows kidney benefits in heart disease study
Jul 1, 2026 07:30AM BridgeBio raises $1 billion in convertible preferred equity
Jun 16, 2026 06:42AM BridgeBio Pharma (BBIO) PT Lowered to $96 at Mizuho
Jun 8, 2026 10:05AM Mizuho on BridgeBio Pharma (BBIO): 'We believe that any such potential transient weakness could represent a potential entry point opportunity'
Jun 3, 2026 05:59AM Canaccord Starts BridgeBio Pharma (BBIO) at Buy
May 26, 2026 03:49AM Raymond James Downgrades BridgeBio Pharma (BBIO) to Market Perform
May 18, 2026 04:15PM Citi Starts BridgeBio Pharma (BBIO) at Neutral
May 12, 2026 07:30AM BridgeBio submits FDA application for rare disease drug encaleret
May 11, 2026 09:31AM BridgeBio shares new acoramidis data showing cardiovascular benefits
May 11, 2026 07:10AM BridgeBio Pharma (BBIO) PT Raised to $110 at H.C. Wainwright
May 8, 2026 06:10AM BridgeBio Pharma (BBIO) files mixed shelf
May 8, 2026 05:06AM BridgeBio Pharma (BBIO) PT Raised to $130 at Evercore ISI
May 8, 2026 12:54AM BridgeBio Pharma Inc. (BBIO) Misses Q1 EPS by 16c
May 6, 2026 07:32AM BridgeBio gets Brazil approval for ATTR-CM heart drug acoramidis
May 1, 2026 06:00AM Barclays sees a buying opportunity in this biotech stock
Apr 29, 2026 07:19AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Apr 28, 2026 03:23PM BridgeBio Pharma (BBIO) PT Raised to $96 at BofA Securities
Apr 28, 2026 02:00PM Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
Apr 28, 2026 12:14PM Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'
Apr 28, 2026 11:46AM TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
Apr 28, 2026 11:41AM RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
Apr 28, 2026 11:34AM William Blair: 'we continue to view BridgeBio as a core smidcap biotech holding'
Apr 28, 2026 11:25AM Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
Apr 28, 2026 09:48AM Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
Apr 28, 2026 09:38AM Barclays: 'We think dropping the question of '441 validity from the case is a major development'
Apr 28, 2026 07:31AM BridgeBio teams with Morgan Freeman to raise awareness of heart condition
Apr 27, 2026 09:29AM Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Apr 27, 2026 06:48AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Apr 20, 2026 10:46AM Mizuho sees Pfizer patent trial as the single largest catalyst for BridgeBio (BBIO) stock this year
View More Recent Stories View Older Stories